日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Flow Cytometric Assessment of FcγRIIIa-V158F Polymorphisms and NK Cell Mediated ADCC Revealed Reduced NK Cell Functionality in Colorectal Cancer Patients

流式细胞术评估FcγRIIIa-V158F多态性和NK细胞介导的ADCC揭示结直肠癌患者NK细胞功能降低

Phillip Schiele ,Stefan Kolling ,Stanislav Rosnev ,Charlotte Junkuhn ,Anna Luzie Walter ,Jobst Christian von Einem ,Sebastian Stintzing ,Wenzel Schöning ,Igor Maximilian Sauer ,Dominik Paul Modest ,Kathrin Heinrich ,Lena Weiss ,Volker Heinemann ,Lars Bullinger ,Marco Frentsch ,Il-Kang Na

Role of beta-(1→3)(1→6)-D-glucan derived from yeast on natural killer (NK) cells and breast cancer cell lines in 2D and 3D cultures

酵母来源的 β-(1→3)(1→6)-D-葡聚糖在 2D 和 3D 培养中对自然杀伤 (NK) 细胞和乳腺癌细胞系的作用

Abdelhadi Boulifa, Martin J Raftery, Alexander Sebastian Franzén, Clarissa Radecke, Sebastian Stintzing, Jens-Uwe Blohmer, Gabriele Pecher

Next-Generation CEA-CAR-NK-92 Cells against Solid Tumors: Overcoming Tumor Microenvironment Challenges in Colorectal Cancer

新一代 CEA-CAR-NK-92 细胞对抗实体瘤:克服结直肠癌的肿瘤微环境挑战

Alexander Sebastian Franzén, Abdelhadi Boulifa, Clarissa Radecke, Sebastian Stintzing, Martin J Raftery, Gabriele Pecher

Enhancement of colorectal cancer therapy through interruption of the HSF1-HSP90 axis by p53 activation or cell cycle inhibition

通过 p53 激活或细胞周期抑制来中断 HSF1-HSP90 轴,增强结直肠癌治疗

Tamara Isermann, Kim Lucia Schneider, Florian Wegwitz, Tiago De Oliveira, Lena-Christin Conradi, Valery Volk, Friedrich Feuerhake, Björn Papke, Sebastian Stintzing, Bettina Mundt, Florian Kühnel, Ute M Moll, Ramona Schulz-Heddergott

Next Generation CD44v6-Specific CAR-NK Cells Effective against Triple Negative Breast Cancer

下一代 CD44v6 特异性 CAR-NK 细胞可有效治疗三阴性乳腺癌

Martin J Raftery, Alexander Sebastian Franzén, Clarissa Radecke, Abdelhadi Boulifa, Günther Schönrich, Sebastian Stintzing, Jens-Uwe Blohmer, Gabriele Pecher

PD-L1 Amino Acid Position 88 Represents a Hotspot for PD-L1 Stability With Relevance for PD-L1 Inhibition

PD-L1 氨基酸位置 88 代表 PD-L1 稳定性的热点,与 PD-L1 抑制相关

Luise Victoria Claaß, Christoph Schultheiß, Rebekka Scholz, Lisa Paschold, Donjete Simnica, Volker Heinemann, Sebastian Stintzing, Mascha Binder

Secondary resistance to anti-EGFR therapy by transcriptional reprogramming in patient-derived colorectal cancer models

患者来源的结直肠癌模型中,转录重编程导致对EGFR抑制剂治疗的继发性耐药

Deepak Vangala # ,Swetlana Ladigan # ,Sven T Liffers ,Soha Noseir ,Abdelouahid Maghnouj ,Tina-Maria Götze ,Berlinda Verdoodt ,Susanne Klein-Scory ,Laura Godfrey ,Martina K Zowada ,Mario Huerta ,Daniel L Edelstein ,Jaime Martinez de Villarreal ,Miriam Marqués ,Jörg Kumbrink ,Andreas Jung ,Tobias Schiergens ,Jens Werner ,Volker Heinemann ,Sebastian Stintzing ,Doris Lindoerfer ,Ulrich Mansmann ,Michael Pohl ,Christian Teschendorf ,Christiane Bernhardt ,Heiner Wolters ,Josef Stern ,Selami Usta ,Richard Viebahn ,Jacob Admard ,Nicolas Casadei ,Stefan Fröhling ,Claudia R Ball ,Jens T Siveke ,Hanno Glimm ,Andrea Tannapfel ,Wolff Schmiegel ,Stephan A Hahn

Random survival forests identify pathways with polymorphisms predictive of survival in KRAS mutant and KRAS wild-type metastatic colorectal cancer patients

随机生存森林可识别具有预测 KRAS 突变型和 KRAS 野生型转移性结直肠癌患者生存的多态性通路

Madiha Naseem, Shu Cao, Dongyun Yang, Joshua Millstein, Alberto Puccini, Fotios Loupakis, Sebastian Stintzing, Chiara Cremolini, Ryuma Tokunaga, Francesca Battaglin, Shivani Soni, Martin D Berger, Afsaneh Barzi, Wu Zhang, Alfredo Falcone, Volker Heinemann, Heinz-Josef Lenz

Prevalence and influence on outcome of HER2/neu, HER3 and NRG1 expression in patients with metastatic colorectal cancer

转移性结直肠癌患者HER2/neu、HER3及NRG1表达的流行情况及对疗效的影响

Arndt Stahler, Volker Heinemann, Jens Neumann, Alexander Crispin, Andreas Schalhorn, Sebastian Stintzing, Clemens Giessen-Jung, Ludwig Fischer von Weikersthal, Ursula Vehling-Kaiser, Martina Stauch, Detlef Quietzsch, Julian W Holch, Stephan Kruger, Michael Haas, Marlies Michl, Jobst von Einem, Thoma